History

This is the footstep of Korea's APIs industry,
which CKD BiO has grown and nurtured.

2010s

“Blossoming as a global company”

2017 Certification of Most Loved Enterprise by younger generation
(Employment and Labor Ministry)
2016 Completion of Yesan Factory in Chungnam Province
(Techno Park, Chungnam)
2014 DMCT designated as "World-class Product"
Designated as "Global Professional company"
(Ministry of Trade, Industry and Energy, Korea)
2013 GMP approval by Italy AIFA
(Acarbose, Rifampicin, Rifamycin Sodium, Potassium Clavulanate, Teicoplanin, Cyclosporine)
GMP approval by WHO(Rifampicin)
2012 GMP approval by Brazil ANVISA(Cyclosporine)
GMP approval by US FDA(Potassium Clavulanate, Demeclocycline Hydrochloride, Rifampicin)
2011 Rifamycin Sodium’s CEP granted by EDQM
Teicoplanin’s CEP granted by EDQM
2010 Acarbose designated as "World-class Product"
(Ministry of Knowledge Economy, Korea)
1Billion Dollar Export Award
(Korea International Trade Association)
Designated as "Advanced Technology Center"
(Ministry of Knowledge Economy, Korea)
Designated as "Korea’s Hidden Champion"
(The Export-Import Bank of Korea)